Viking Therapeutics Inc

The current institutional shareholding score of Viking Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 72.58%, representing a quarter-over-quarter increase of 10.67%. The largest institutional shareholder is ETHSX, holding a total of 293.43K shares, representing 0.25% of shares outstanding, with 635.29% increase in holdings.